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Genome scans indicate a linkage of autism to the chromosome 7q21–q36 region. Recent studies suggest that the Reelin gene may be one of the
loci contributing to the positive linkage between chromosome 7q and autism. However, these studies were relatively small scale, using a few
markers in the gene. We investigated 34 single nucleotide polymorphisms (SNPs) in the Reelin gene with an average spacing between the SNPs of
15 kb for evidence of association with autism. There were significant differences in the transmission of the alleles of exon 22 and intron 59 SNP to
autistic subjects. Our findings support a role for the Reelin gene in the susceptibility to autism.
D 2005 Elsevier Inc. All rights reserved.Keywords: Reelin; AutismAutism is a complex trait with a significant genetic
component [1–3]. Recent genome screening studies found
that multiple regions distributed over many chromosomes
had a multipoint maximum lod score greater than 1 [4–10].
The most consistent results were for the 7q21–q32 region.
The Reelin gene (approved gene symbol RELN) locus maps
to chromosome 7q22 between D7S658 (113.92 cM) and
D7S1532 (113.92 cM) on the Marshfield map, in proximity
to or within the portion of chromosome 7q yielding positive
lod scores in most autism linkage studies published to date.
Reelin is a large secreted extracellular matrix protein
implicated in modulation of neuronal signaling, synaptic
transmission, and plasticity [11]. It plays a pivotal role in
the development of laminar structures, including the cerebral
cortex, hippocampus, cerebellum, and brain-stem nuclei.
Reelin controls cortical layering by signaling through the
very low density lipoprotein receptor and apolipoprotein E
receptor 2, thereby inducing tyrosine phosphorylation of the
adaptor protein Disabled-1 and suppressing tau phosphory-
lation in vivo [12]. Several recent studies suggest Reelin
may be one of the loci contributing to the positive linkage
between chromosome 7q and autistic disorder. Biochemical0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ygeno.2005.09.008
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E-mail address: ahuq@med.wayne.edu (A.H.M.M. Huq).analyses of postmortem autistic brain point to Reelin as
being involved in the pathology of autism [13]. Blood levels
of unprocessed Reelin (410 kDa) are significantly reduced in
autistic twins, their fathers, their mothers, and their
phenotypically normal siblings versus controls [14]. Linkage
disequilibrium of autism with variants in the Reelin gene
has also been reported, but not confirmed in other studies
[15–21]. However, these studies were relatively small scale,
using a few markers in the gene. Reelin may also influence
other neurodevelopmental disorders including schizophrenia,
bipolar disorder, major depression, and lissencephaly
[22,23].
We investigated 34 single nucleotide polymorphisms
(SNPs), including five coding and splice region SNPs in the
Reelin gene for association with autism. These SNPs are
annotated in the dbSNP database and include a G/C SNP in
exon 22 (dbSNP: rs362691, V997L), a C/G SNP in exon 34
(dbSNP: rs2229860, P1703R), an A/G polymorphism in exon
45 (dbSNP: rs362746, V2370V), and a G/A SNP in exon 48
(dbSNP: rs2075038, P2510P). We also investigated an A/G
transversion (dbSNP: rs607755) located in the 5V splice
junction of exon 6. This SNP has been previously studied in
autistic subjects and is expected to affect splicing of the Reelin
pre-mRNA [15]. The polymorphisms in exon 22 (L997V) and
exon 34 (P1703R) alter amino acid composition of the Reelin
protein. The average spacing between the SNPs was 15 kb.06) 75 – 83
www.el
Table 1
Summary of pedigrees used in this study
Affected subjects per pedigree Broad diagnosis Narrow diagnosis
1 4 67
2 179 124
3 15 4
4 2 1
Total pedigrees 200 196
The narrow category includes individuals with a diagnosis of autism based on
the Autism Diagnostic Interview-Revised (ADI-R). Broad diagnosis includes in
addition those who narrowly miss meeting the ADI-R criteria and those who
are diagnosed with PDD or Asperger syndrome.
F.J. Serajee et al. / Genomics 87 (2006) 75–8376Our studies revealed significant differences in the transmission
of the alleles of SNPs in exon 22 and intron 59 to autistic
subjects.
Results and discussion
We investigated 196 Caucasian families ascertained through
the Autism Genetics Resource Exchange (AGRE). TheTable 2
Reelin gene SNPs investigated in our studies
SNP dbSNP ID Location Allele Amino acid Allele frequenc
1 rs12538307 5V UTR C/T  0.65/0.35
2 rs7800855 Intron 1 A/G  0.28/0.72
3 rs722277 Intron 1 A/G  0.44/0.56
4 rs3735630 Intron 1 A/G  0.51/0.49
5 rs2299395 Intron 2 A/G  0.93/0.07
6 rs2299388 Intron 2 C/T  0.94/0.06
7 rs39360 Intron 3 A/C  0.41/0.59
8 rs39353 Intron 3 A/C  0.41/0.59
9 rs264373 Intron 3 C/G  0.50/0.50
10 rs2237635 Intron 4 C/G  0.24/0.76
11 rs607755 Intron 6 A/G  0.53/0.47
12 rs661575 Intron 7 C/T  0.63/0.37
13 rs3213611 Intron 7 C/T  0.89/0.11
14 rs2237632 Intron 8 A/G  0.11/0.89
15 rs2283023 Intron 9 A/C  0/1
16 rs2073559 Intron 11 C/T  0.51/0.49
17 rs2073557 Intron 11 A/G  0.43/0.57
18 rs2240965 Intron 13 C/T  0.76/0.24
19 rs2073551 Intron 16 G/T  0.34/0.66
20 rs977639 Intron 20 C/T  0.11/0.89
21 rs362691 Exon 22 C/G V997L 0.89/0.11
22 rs123714 Intron 24 C/T  0.29/0.71
23 rs123713 Intron 27 C/T  0.28/0.72
24 rs144525 Intron 28 A/G  0.69/0.31
25 rs362726 Intron 31 C/T  0.62/0.38
26 rs2229860 Exon 34 C/G P1703R 0.995/0.005
27 rs362746 Exon 45 A/G V2370V 0.97/0.03
28 rs362710 Intron 46 C/T  0.69/0.31
29 rs2256658 Intron 46 C/T  0.09/0.91
30 rs2075038 Exon 48 A/G P2510P 0.02/0.98
31 rs736707 Intron 59 C/T  0.23/0.77
32 rs17150616 Exon 60 C/T A3358A 0.12/0.88
33 rs3808045 Intron 61 C/T  0.15/0.75
34 rs7811571 3V UTR A/G  0.997/0.003
These SNPs were genotyped in 196 AGRE families. The reference ID, location with
Weinberg equilibrium check, and power to detect association at a significance l
proportions.summary of pedigrees used in this study is shown in Table 1.
The male–female ratio for autistic subjects was 3.5, consistent
with increased prevalence of the disorder in boys. The mean
age of the children at the time of testing was 7 years. The
probands tested negative for possible secondary autism such as
inverted duplication of chromosome 15, abnormal neurological
examination or neuroimaging, chromosomal abnormalities,
perinatal trauma, or an identified genetic syndrome such as
Fragile X. Families with identical twins were also excluded
from the study due to concerns of possible environmental
factors.
The exon 6 splice region SNP was genotyped using
restriction enzyme digestion-based assay [15]. The remaining
28 SNPs were genotyped by high-throughput single-base
primer extension assay through Orchid BioSciences (exons
34, 45, and 48) and Genaissance. The DNA sequences for
designing genotyping assays were obtained from the dbSNP
database at http://www.ncbi.nlm.gov/SNP/. The high-through-
put genotyping assays were developed, validated, and
performed at the genotyping facilities of Orchid BioSciences
and Genaissance. The reference ID, location within gene,y Genotyping rate Mendelian error rate HWE p value Power
0.93 0 0.34 0.99
0.92 0 0.08 0.99
0.99 0.003 0.82 0.99
0.94 0.003 0.73 0.99
0.98 0.003 0.19 0.99
0.98 0.003 0.54 0.98
0.92 0.003 0.46 0.99
0.91 0.003 0.9 0.99
0.92 0.05 0.01 0.97
0.97 0 0.84 0.99
0.95 0 1 0.98
0.96 0.01 0.83 0.99
0.97 0.001 0.77 0.99
0.98 0.001 0.9 0.99
0.97 0.005 N/A 0
0.92 0.003 0.35 0.99
0.94 0.01 0.67 0.99
0.96 0.003 0.03 0.99
0.97 0.005 0.32 0.99
0.93 0 0.55 0.99
0.93 0 1 0.99
0.98 0.001 0.68 0.99
0.99 0 0.43 0.99
0.90 0.008 0.09 0.99
0.97 0.005 0.4 0.99
0.80 0 1 0.002
0.96 0 0.05 0.68
0.99 0.006 0.29 0.99
0.96 0.02 0.03 0.99
0.98 0 1 0.33
0.95 0.003 0.006 0.99
0.87 0.01 0.4 0.99
0.90 0.002 0.63 0.99
0.94 0 0.98 0.002
in gene, alleles, amino acid change, allele frequencies, genotyping rate, Hardy-
evel of 5  108 are shown. HWE indicates p values for Hardy-Weinberg
F.J. Serajee et al. / Genomics 87 (2006) 75–83 77alleles, amino acid change, allele frequencies, genotyping
rate, Mendelian error rate, Hardy–Weinberg equilibrium
check, and power to detect association at a significance level
of 5  108 are shown in Table 2. Five SNPs in intron 3,
intron 13, exon 45, intron 46, and intron 59 demonstrated
deviation from Hardy–Weinberg equilibrium ( p value not
corrected for multiple testing).
We calculated the power of our studies for the different
SNPs using the TDT-PC v1.2 program (http://biosun01.
biostat.jhsph.edu/~wmchen/pc.html) [24,25]. Assuming a gene
effect with genotypic relative risk, g = 6.0 for the
homozygote, and g = 3.0 for the heterozygote, we had
sufficient power to detect association at a significance level of
a = 1  108 for all SNPs except SNPs 24, 25, and 28
(dbSNP rs2229860, rs362746, and rs2075038) (Table 2).
However, we had less than 50% power to detect an
association for a variant with genotypic relative risk g =
4.0 for the homozygote. We also had less than 50% power to
detect association with rare variants (minor allele frequency
less than 0.2) or where linkage disequilibrium between
marker and risk allele was less than 0.8. We used a very
conservative level of significance of 5  108 for the power
calculation to account for multiple testing of potentiallyFig. 1. Linkage disequilibrium among the SNPs in the Reelin gene. The coeffic
frequency and the frequency expected under statistical independence. The DV m
from 1 to +1, with 1 and +1 representing complete LD and 0 representin
Tables 2–5.thousands of variants that can be tested in this sample. Recent
data suggest that as more SNPs are genotyped, increasing
numbers of spurious signals that are stronger than those
created by real disease predisposing alleles will be derived
[26]. It has been suggested that association studies should be
considered as a means to investigate provisionally large sets
of genes, to identify polymorphisms that are potentially in
linkage disequilibrium with the trait [26]. Replication will
then be required to differentiate the real associations from the
spurious ones.
Since neighboring SNPs, if sufficiently close, will be
inherited with a disease-causing SNP, the inheritance of a
haplotype can be used to tag a region of the genome
uniquely for closer study. The Reelin gene encompasses 500
kb of genomic DNA with an average spacing between the
SNPs of 15 kb. Inspection of the intermarker linkage
disequilibrium (LD) (Fig. 1) with the GOLD software
package shows that not all marker pairs exhibited a useful
level of LD (DV > 0.7). However there were useful levels of
LD between the SNPs in the regions from intron 11 to intron
28.
Family-based association analyses were performed using
the transmission disequilibrium test (TDT), in which prefer-ient of disequilibrium, D, is the difference between the observed haplotype
easure is a proportion of the maximum value of D, whose range extends
g free association. SNPs 1 to 34 correspond to the dbSNP IDs shown in
F.J. Serajee et al. / Genomics 87 (2006) 75–8378ential allelic transmission from heterozygous parents to
affected offspring is tested by applying the (b  c)2/(b +
c) statistics and the m2 test [27]. The transmission ratio
(transmitted/not transmitted) and the 95% confidence interval
around the transmission ratio were calculated for each allele
of the SNPs. Under a multiplicative model the transmission
ratio is an estimator of the genotype relative risk [28]. TDT
was performed using UNPHASED, which is a suite of
programs for association analysis of multilocus haplotypes
from unphased genotype data [29]. Tables 3 and 4 demon-
strate results of TDT and TDT-AE studies. There was a
significant difference in the transmission of the alleles of a C/
T SNP in intron 59 (corrected p value 0.0005) and a C/G
SNP in exon 22 (corrected p value 0.003) to autistic subjects,
when a broad diagnosis of autism was considered. A
synonymous A/G SNP in exon 48 also demonstrated
nominally significant difference in the transmission of alleles
to the autistic subjects. TDT-AE revealed similar findings.
TDT-AE is a likelihood-based transmission disequilibriumTable 3
TDT and TDT-AE analyses of the SNPs in the Reelin gene using broad criteria fo
SNP dbSNP ID TDT
T/NT LRS p value p value C
1 rs12538307 71/82 0.79 0.37 0.34
2 rs7800855 66/64 0.03 0.86 0.94
3 rs722277 142/165 1.72 0.18 0.68
4 rs3735630 129/140 0.45 0.5 0.94
5 rs2299395 44/35 1 0.31 0.81
6 rs2299388 82/78 0.1 0.75 0.98
7 rs39360 115/115 0 1 1.00
8 rs39353 123/127 0.06 0.8 1.01
9 rs264373 159/122 4.64 0.03 0.26
10 rs2237635 48/55 0.48 0.49 0.98
11 rs607755 138/157 1.2 0.27 0.77
12 rs661575 139/147 0.22 0.64 0.91
13 rs3213611 61/56 0.21 0.64 0.95
14 rs2237632 61/62 0.008 0.92 0.98
15 rs2283023 63/53 0.86 0.35 0.85
16 rs2073559 123/124 0.34 0.56 0.91
17 rs2073557 139/146 0.17 0.68 0.92
18 rs2240965 117/99 1.5 0.22 0.75
19 rs2073551 147/139 0.22 0.64 0.99
20 rs977639 45/65 3.66 0.06 0.41
21 rs362691 83/43 9.47 0.002 0.03
22 rs123714 137/127 0.38 0.54 0.92
23 rs123713 138/127 0.48 0.49 1.04
24 rs144525 116/119 0.04 0.84 0.95
25 rs362726 160/137 1.78 0.18 0.77
26 rs2229860 1/0 1.39 0.24 0.74
27 rs362746 8/9 0 1 1.03
28 rs362710 158/128 2.58 0.11 0.53
29 rs2256658 38/44 0.44 0.51 0.91
30 rs2075038 4/14 5.23 0.02 0.23
31 rs736707 106/52 18.83 1.40  105 0.0005
32 rs17150616 40/42 0.05 0.83 1.01
33 rs3808045 43/41 0.048 0.84 0.98
34 rs7811571 2/0 2.7 0.09 0.51
TDT was performed by TDTPHASE software. LRS indicates value of the likelih
not transmitted; ratio, transmission ratio (T/NT). Under a multiplicative model t
allows genotyping errors in the analysis of SNP data. p value C indicates after
testing.test, which maintains a correct type I error rate in the
presence of random genotyping errors [32]. Traditional TDT
assumes that genotype data are errorless.
Family-based association analyses were also performed
using PDT (pedigree disequilibrium test), which is a variation
of TDT developed for use in general pedigrees [30,31]. As
multiple affected sibs in each family were genotyped for some
SNPs, traditional TDT may not be a valid test for association
[27]. PDT provides a general and valid test of linkage
disequilibrium in such situation [30,31]. The PDT results are
shown in Table 5. The most significant result was for a C/T
SNP in intron 59 (corrected p value 0.003), when a broad
diagnosis of autism was considered. The common C allele
was more often transmitted. There was also a nominally
significant difference in the transmission of the alleles of C/G
SNP in exon 22 ( p = 0.02) to autistic subjects. The common
G allele, which corresponds to valine at amino acid position
997, was more often transmitted. A synonymous A/G SNP in
exon 48 also demonstrated a nominally significant ( p = 0.03)r diagnosis of autism
Ratio (T/NT) 95% CI for ratio TDT-AE
LRS p value p value C
0.87 0.63–1.19 0.79 0.37 1
1.03 0.73–1.46 0.03 0.86 1
0.86 0.69–1.08 1.64 0.20 0.85
0.92 0.72–1.17 0.5 0.48 1
1.26 0.81–2.00 0.34 0.56 1
1.05 0.77–1.44 0.004 0.95 0.98
1.00 0.77–1.30 0.015 0.90 1
0.97 0.75–1.24 0.03 0.86 1
1.30 1.03–1.66 3.5 0.06 0.41
0.87 0.59–1.28 0.49 0.48 1
0.88 0.70–1.10 1.18 0.28 0.95
0.95 0.75–1.19 0.48 0.49 1
1.09 0.76–1.58 0.09 0.76 1
0.98 0.69–1.41 0.004 0.95 1
1.19 0.83–1.73 0.18 0.67 1
0.99 0.77–1.27 0.33 0.57 0.97
0.95 0.75–1.20 0.13 0.72 1
1.18 0.91–1.55 1.08 0.3 0.93
1.06 0.84–1.34 0.15 0.70 1
0.69 0.46–1.00 3.66 0.06 0.5
1.93 1.36–2.87 9.47 0.002 0.05
1.08 0.85–1.38 0.46 0.50 0.94
1.09 0.85–1.39 0.46 0.50 1
0.97 0.75–1.26 0.61 0.44 1
1.17 0.93–1.47 1.58 0.21 0.79
0 1.00 1
0.89 0.30–2.42 0.06 0.81 1
1.23 0.98–1.56 1.93 0.16 0.91
0.86 0.55–1.33 0.007 0.94 1
0.29 0.03–0.71 6.97 0.009 0.1
2.04 1.49–2.91 17.51 0.0001 0.003
0.95 0.61–1.48 0.02 0.89 1
1.05 0.68–1.62 0.16 0.69 1
1.6 0.2 0.97
ood ratio statistic in TDTPHASE and TDT-AE analyses. T, transmitted; NT,
he transmission ratio is an estimator of the genotype relative risk. TDT-AE
p value Benjamini and Hochberg false recovery rate correction for multiple
Table 4
TDT and TDT-AE analyses of the SNPs in the Reelin gene using strict criteria for diagnosis of autism
SNP dbSNP ID TDT Ratio
(T/NT)
95% CI for ratio TDT-AE
T/NT LRS p value p value C LRS p value p value C
1 rs12538307 57/64 0.41 0.52 1 0.89 0.62–1.27 0.41 0.52 1
2 rs7800855 49/53 0.16 0.69 0.98 0.92 0.62–1.37 0.16 0.69 1
3 rs722277 98/125 3.3 0.07 0.79 0.78 0.6–1.02 2.9 0.09 1
4 rs3735630 99/94 0.13 0.72 0.91 1.05 0.79–1.4 0.13 0.72 0.94
5 rs2299395 33/26 0.83 0.36 1 1.27 0.76–2.18 0.86 0.35 1
6 rs2299388 63/55 0.54 0.46 1 1.15 0.8–1.66 0.17 0.68 1
7 rs39360 80/85 0.15 0.7 0.95 0.94 0.69–1.28 0.04 0.83 0.94
8 rs39353 89/95 0.2 0.66 0.97 0.94 0.7–1.25 0.12 0.73 0.92
9 rs264373 108/91 1.5 0.23 1 1.19 0.9–1.58 0.33 0.57 1
10 rs2237635 32/36 0.24 0.63 0.97 0.89 0.54–1.43 0.24 0.63 1
11 rs607755 102/97 0.13 0.72 0.94 1.05 0.8–1.39 0.001 0.97 0.97
12 rs661575 95/107 0.71 0.4 1 0.89 0.67–1.17 0.52 0.47 1
13 rs3213611 49/43 0.39 0.53 1 1.14 0.76–1.74 0.39 0.53 1
14 rs2237632 48/47 0.01 0.92 0.98 1.02 0.68–1.54 0.01 0.92 1
15 rs2283023 46/39 0.58 0.45 1 1.18 0.77–1.83 0.14 0.71 0.96
16 rs2073559 87/73 0.09 0.76 0.89 1.19 0.87–1.64 0.07 0.8 0.94
17 rs2073557 91/100 0.42 0.51 1 0.91 0.68–1.21 0.14 0.71 1
18 rs2240965 78/68 0.69 0.41 1 1.15 0.83–1.6 0.52 0.47 1
19 rs2073551 99/98 0.01 0.94 0.97 1.01 0.76–1.34 0.003 0.96 1
20 rs977639 34/49 2.7 0.09 0.8 0.69 0.44–1.06 2.73 0.1 0.85
21 rs362691 51/38 1.9 0.17 1 1.34 0.89–2.08 1.91 0.17 1
22 rs123714 87/84 0.05 0.82 0.93 1.04 0.77–1.4 0.16 0.69 1
23 rs123713 89/84 0.09 0.76 0.92 1.06 0.79–1.43 0.16 0.69 1
24 rs144525 86/84 0.02 0.88 0.97 1.02 0.76–1.39 0.001 0.97 1
25 rs362726 106/99 0.24 0.62 1 1.07 0.81–1.41 0.09 0.76 0.92
26 rs2229860 1/0 1.4 0.24 1  0.81 0.37 1
27 rs362746 8/6 0.29 0.59 1 1.33 0.45–4.91 0.97 0.32 1
28 rs362710 104/87 1.5 0.22 1 1.20 0.9–1.6 0.58 0.45 1
29 rs2256658 26/30 0.29 0.59 1 0.87 0.5–1.47 0.21 0.66 1
30 rs2075038 3/10 3.98 0.05 0.85 0.30 0–0.85 3.14 0.09 1
31 rs736707 74/37 12.57 0.0004 0.01 2.00 1.38–3.07 10.12 0.002 0.07
32 rs17150616 33/28 0.41 0.52 1 1.18 0.71–1.99 1.03 0.31 1
33 rs3808045 36/30 0.55 0.46 1 1.20 0.74–1.99 0.86 0.36 1
34 rs7811571 1/0 1.4 0.24 1  0.81 0.37 1
TDT was performed by TDTPHASE software. LRS indicates value of the likelihood ratio statistic in TDTPHASE and TDT-AE analyses. T, transmitted; NT,
not transmitted; ratio, transmission ratio (T/NT). Under a multiplicative model the transmission ratio is an estimator of the genotype relative risk. TDT-AE
allows genotyping errors in the analysis of SNP data. p value C indicates after p value Benjamini and Hochberg false recovery rate correction for multiple
testing.
F.J. Serajee et al. / Genomics 87 (2006) 75–83 79difference in the transmission of alleles to the autistic
subjects. There was no sex difference in the transmission of
variants.
Although we investigated a total of 34 SNPs, due to the
large size of Reelin genes, a sufficient degree of LD (>0.7)
was not present between the SNPs to be useful for haplotype
studies (Fig. 1). Linkage disequilibrium study with a denser
map of SNPs and improved understanding of the haplotype
structure in the AGRE sample will be required to tag the
region of the Reelin gene containing any putative etiologic
variant.
Our results suggest an association of autism with a SNP
in intron 59 of the Reelin gene. Although TDT studies
revealed significant results for exon 22 SNP, only intron 59
SNP remains significant in PDT studies after Benjamini and
Hochberg false recovery rate correction for multiple testing
[35]. At present, there is no general consensus as to how to
correct for multiple testing in genetic association studies
[36]. As the SNPs are related, Bonferroni correction is tooconservative and may not be appropriate [37]. Although
Benjamini and Hochberg false recovery rate correction is
less stringent than Bonferroni correction, it provides a
good balance between discovery of statistically significant
associations and limitations of false positive occurrences
[35].
The analyses in this study were conducted using a broad
diagnostic definition. When strict criteria for diagnosis of
autism are used, similar but less significant results were
obtained (Tables 3 and 4). The more significant results with
a broad diagnosis definition may be due to additional
information that is gained by inclusion of more affected
individuals who do not meet the strict criteria for diagnosis
of autism. Alternatively, this may be an indication of biased
results.
In our study the common allele of intron 59 SNP was
more often transmitted to autistic subjects, suggesting that
the rare allele is associated with a protective effect, although
one must consider chance nontransmission of the rare allele.
Table 5
PDT analyses of the SNPs in the Reelin gene
SNP dbSNP ID Strict diagnosis PDT Broad diagnosis PDT
m2 p value p value C m2 p value p value C
1 rs12538307 0.2 0.9 1 0.045 0.83 1
2 rs7800855 1.1 0.28 1 0.16 0.68 1
3 rs722277 2.9 0.09 0.77 1.07 0.30 0.78
4 rs3735630 0.13 0.71 1 1.20 0.27 0.83
5 rs2299395 0.58 0.45 1 1.43 0.23 0.78
6 rs2299388 0.14 0.71 1 0.04 0.85 0.99
7 rs39360 0.02 0.89 1 0.009 0.93 0.99
8 rs39353 0.18 0.67 1 0.01 0.92 1
9 rs264373 0 1 1 1.67 0.20 0.85
10 rs2237635 0.21 0.65 1 0.11 0.74 1
11 rs607755 0.08 0.78 1 1.97 0.16 0.91
12 rs661575 0.3 0.58 1 2.41 0.12 0.82
13 rs3213611 0.28 0.6 1 0.25 0.62 0.96
14 rs2237632 0.04 0.84 1 0.27 0.61 0.99
15 rs2283023 0.04 0.84 1 1.72 0.19 0.92
16 rs2073559 0.004 0.95 1 0.38 0.54 1
17 rs2073557 0.005 0.95 1 0.05 0.83 1
18 rs2240965 0.49 0.48 1.3 1.14 0.29 0.82
19 rs2073551 0.02 0.9 1 0.03 0.87 0.99
20 rs977639 3.7 0.06 1 3.99 0.05 0.42
21 rs362691 1.8 0.18 1 5.98 0.02 0.34
22 rs123714 0.23 0.53 1 0.31 0.58 1
23 rs123713 0.17 0.68 1 0.09 0.77 1
24 rs144525 0 1 1 0.96 0.33 0.70
25 rs362726 0.005 0.95 1 1.54 0.21 0.79
26 rs2229860 1 0.32 1 1 0.32 0.72
27 rs362746 0.33 0.57 1 0 1 1
28 rs362710 0.1 0.74 1 1.04 0.31 0.75
29 rs2256658 0.49 0.48 1 0.72 0.4 0.8
30 rs2075038 3 0.08 0.9 5 0.03 0.34
31 rs736707 7.1 0.007 0.24 15.15 0.0001 0.003
32 rs17150616 1.1 0.3 1 0.10 0.75 1
33 rs3808045 0.7 0.4 1 0.29 0.59 1
34 rs7811571 0 1 1 0 1 1
PDT is a form of TDT suitable for analysis of general pedigrees such that all
family data may be used without nullifying the validity of the association test,
even when there is more than one affected in a family. p value C indicates after
p value Benjamini and Hochberg false recovery rate correction for multiple
testing.
F.J. Serajee et al. / Genomics 87 (2006) 75–8380The most significant result was obtained with the SNP in
intron 59. In TDT studies, there were significant differences
in the transmission of alleles of exon 22 and tendencies
toward significance for exon 48 SNPs, but after correction
for multiple testing only the result for intron 59 was
significant in PDT studies. The C/G SNP in exon 22
corresponds to a conservative amino acid change and the
G/A SNP in exon 48 (P2501P) does not cause any alteration
in amino acid composition. It is likely that intron 59 SNP is
not an etiologic variant, but may be in linkage disequilibrium
with an etiologic variant. However, there is a steadily
accumulating body of evidence to support a role for intronic
variants in complex diseases [38]. As the linkage disequi-
librium pattern in the Reelin gene is incompletely under-
stood, it is difficult to assess the source of the association
signal. Investigation of three additional markers distal to
intron 59 SNP did not reveal any association, suggesting that
the association signal is unlikely to be due to a mutation in a
gene 3V of Reelin.It is to be noted that intron 3, intron 13, exon 45, and intron
59 SNPs demonstrated deviations from Hardy–Weinberg
proportions (HWE). The p values for the deviation from
HWE for these SNPs were 0.01, 0.03, 0.05, and 0.006; these p
values were not corrected for multiple testing. If one routinely
performs testing for Hardy–Weinberg proportions for a large
number of loci, deviations from HWE for some loci are to be
expected. The deviation from expected proportions for intron
59 SNP raises the possibility that the association signal may
be due to nonrandom genotyping errors. However, in a
recently published association study, the intron 59 SNP was
nominally significant in 85 families from AGRE, suggesting
that the association signal from intron 59 in this study is real
[21].
Linkage disequilibrium of autism with variants in the
Reelin gene has been investigated before [15–17]. The
Reelin gene 5V untranslated region contains a low and
variable number of GCG repeats, and this has been
correlated with genetic susceptibility to autism [15]. Other
studies, however, demonstrated no association [16] or
equivocal results [17] for the 5V GCG repeats. AGRE
families have previously been used in genetic studies of
Reelin [17,21]. The most significant association identified in
two previous studies with AGRE samples was for the 5V
UTR GGC repeat; however, in one study a nominally
significant difference in the transmission of intron 59 alleles
was found [21]. In this study, the 5V UTR repeat was not
studied, but the intron 59 SNP demonstrated significant
difference in transmission of alleles to autistic subjects,
while polymorphisms in exon 22 and exon 48 demonstrated
a trend toward significant difference in the transmission to
autistic subjects. Increased transmission was obtained for the
frequent allele of intron 59. Although the association could
be real, and the common allele could be the disease-causing
mutation, from a population genetics perspective, it is
unlikely that a disease-causing mutation will become the
common allele in the population unless the allele confers
some selective advantage. The common allele may, however,
be in linkage disequilibrium with another disease-predispos-
ing allele. Alternatively, undetected genotyping errors may
cause apparent overtransmission of the common allele in a
transmission disequilibrium test [39]. The sequence of
Reelin protein begins with a signal peptide followed by a
region with similarity to F-spondin, a unique region, and
then eight 300-amino-acid-long repeats. Exon 22 corre-
sponds to the second repeat of the Reelin protein, whereas
exon 48 corresponds to the sixth repeat. The exon 22 G/C
SNP causes a valine to leucine change in amino acid
position 997, which is a conservative change in the Reelin
protein in the region of the second repeat. Review of the
databases suggests that leucine is the common allele in rat
and chick, while valine is the common allele in human and
mouse. The exon 22 SNP has been studied previously.
Bonora et al. did not find any evidence of association of the
exon 22 SNP, but they reported a trend toward transmission
disequilibrium of maternal alleles of an intron 31 SNP,
which was in linkage disequilibrium with the exon 22 SNP.
F.J. Serajee et al. / Genomics 87 (2006) 75–83 81In a recent study, a trend toward significance was observed
for SNPs in exons 6, 45, and 50 [21] in a subset of autism
samples.
PI3-kinase (PIK3) interacts with the adaptor protein Dab1
in response to Reelin signaling and is required for normal
cortical lamination, suggesting that PI3-kinase signaling is
involved in Reelin’s regulation of neuronal position during
brain development [33,34]. This is of interest as PIK3
signaling is disrupted in tuberous sclerosis, a condition with
a very high risk for autism. We have previously reported a
nominally positive association of autistic spectrum disorder
with variants in PIK3CG and INPP1, two genes that map to
areas of linkage to autism and act in the PIK3 pathway [40].
We performed TDT studies of Reelin while conditioning at the
loci of the PIK3CG and INPP1 genes. There was no evidence
of interaction between the two loci and Reelin variants (data
not shown).
There is a debate as to whether de novo sporadic
mutations in a single gene or a multilocus model involving
two or more interacting loci underlie the autistic phenotype
[41,42]. A recent study reported novel missense variants in
autistic subjects that were absent in a large control group;
however, the low frequency of these mutations did not
explain the relatively strong linkage results on 7q [18]. It is
to be noted that our study relies on the hypothesis that
common variants underlie susceptibility to common diseases.
Our findings provide additional evidence of a role for Reelin
gene polymorphisms in the susceptibility to autism. Investi-
gation of independent samples will help to determine whether
our results represent true associations or spurious chance
findings.Materials and methods
Subjects
The study protocol was approved by the Institutional Review Board at
Wayne State University. DNA samples from 196 autistic disorder Caucasian
families were obtained from AGRE. AGRE, developed and maintained by the
Cure Autism Now Foundation, is a central repository of family DNA samples
for genetic studies of autism [43]. Medical histories, physical neurological
exam data, Peabody scores, Autism Diagnostic Interview—Revised (ADI-R),
Autism Diagnostic Observation Scale, Vineland Adaptive Behavior Scales,
Raven Progressive Matrices, and handedness testing results with all interview
data points and computer-scored algorithm results are available at the AGRE
Web site (http://www.agre.org). Diagnoses were confirmed using the ADI-R
protocol [44]. Criteria for different diagnostic categories within the spectrum of
autism disorders are available at the AGREWeb site (http://www.agre.org). The
narrow category includes individuals with a diagnosis of autism based on the
ADI-R. For this study, we also used a broad diagnostic definition, and all
subjects with a diagnosis of autism, Asperger syndrome, and ‘‘not quite autism’’
(NQA) were considered affected. The broad diagnostic category encompasses
‘‘broad spectrum’’ subjects ranging from mildly to severely impaired and
includes individuals who were categorized as having a disorder that was NQA,
as well as subjects with pervasive developmental disorder and Asperger
syndrome. NQA represents individuals who are no more than 1 point away
from meeting criteria for autism in any or all of the three content domains or
individuals who meet criteria in all domains but do not meet age-at-onset
criteria. Thus, they are individuals who narrowly miss meeting the ADI-R
criteria. Broad spectrum defines individuals ranging from mildly to severely
impaired.Genotyping
SNPs were selected from databases such as the dbSNP, human genome
variation database, and human gene mutation database, which are representa-
tive of the Caucasian population and are thus relevant to the Caucasian families
from AGRE that were investigated in this study. The exon 6 SNP was
genotyped using a restriction enzyme digestion-based assay. The primers and
the PCR conditions for assays for SNPs were as described before [15]. The
remaining SNPs were genotyped by either a high-throughput single-base
primer extension assay through Orchid BioSciences’ SNPstream UHT services
(http://www.orchid.com), which uses fluorescence detection (exons 34, 45,
and 48) or through Genaissance (http://www.genaissance.com), which
employs Sequenom’s MassARRAY platform and mass spectrometry to detect
the primer extension products (remaining 30 SNPs). Single-base primer
extension involves the annealing of an oligonucleotide primer to a single-
stranded PCR amplicon at a location that lies immediately adjacent to, but not
including, the polymorphic SNP site, followed by the addition of a DNA
polymerase and subsequent enzymatic extension of the primer in the presence
only of chain-terminating dideoxynucleotides, which are labeled to facilitate
subsequent detection of the identity of the single incorporated nucleotide. Each
of the primer extension products has also a unique molecular weight that
allows the associated genotype to be precisely identified using mass
spectrometry.
Statistical and genetic analysis
The PedCheck and Merlin programs were used to detect genotyping
errors [45,46]. Mistyping analyses were also performed using Sim Walk2
[47]. Marker allele frequencies were obtained by counting parental
genotypes. Linkage disequilibrium between the markers was analyzed by
the Sim Walk2 and GOLD software packages using parental gametic
haplotypes [47,48]. Family based association analyses were performed using
the TDT and PDT [31]. The PDT analysis program allows the analysis of all
family data, even when there is more than one affected in a family and thus
results in substantial gains in power compared to traditional TDT.
Association analyses were also performed with TDT-AE, which is a
transmission disequilibrium test that allows for random genotyping errors
[32].
For TDT analyses, we used UNPHASED, which is a suite of programs
for association analysis of multilocus haplotypes from unphased genotype
data [49]. This program provides both global p values, which assess the
significance of transmission distortion for all the test haplotypes, and p
values that assess the significance of transmission distortion for specific
haplotypes. Permutation or bootstrap test procedure for testing significance
is available in UNPHASED, when the m2 approximations are not
appropriate. UNPHASED provides association tests conditioning on
additional loci that may already be associated and in linkage disequilibrium
with the test loci. For phase-certain haplotype data, this is the Conditional
ETDT [50,51]; when haplotypes are uncertain, the test is of equality of
odds ratios for haplotypes identical at conditioning loci. There is no specific
test for gene–gene interaction, but the likelihoods under various options can
be compared to test certain hypotheses. For example, comparing the
alternative likelihoods for the conditional test with and without the
maineffects option gives a test for interactions between test and con-
ditioning loci.
The program TDT Power Calculator (TDT-PC v1.2), based on Knapp’s
first approximation, was used to estimate power for the association analyses
[24,25].
Acknowledgments
The study described here was supported in part by grants
from the Cure Autism Now Foundation, the Child Neurology
Foundation, and the Children’s Research Center of Michigan.
We gratefully acknowledge the resources provided by the
AGRE Consortium and the participating AGRE families and
F.J. Serajee et al. / Genomics 87 (2006) 75–8382acknowledge support from the Autism Genetic Resource
Exchange (AGRE).
References
[1] A. Pickles, et al., Latent-class analysis of recurrence risks for
complex phenotypes with selection and measurement error: a twin
and family history study of autism, Am. J. Hum. Genet. 57 (1995)
717–726.
[2] S.E. Folstein, J. Piven, Etiology of autism: genetic influences, Pediatrics
87 (1991) 767–773.
[3] A. Bailey, et al., Autism as a strongly genetic disorder: evidence from a
British twin study, Psychol. Med. 25 (1995) 63–77.
[4] International Molecular Genetic Study of Autism Consortium, A full
genome screen for autism with evidence for linkage to a region on
chromosome 7q, Hum. Mol. Genet. 7 (1998) 571–578.
[5] A. Philippe, et al., Genome-wide scan for autism susceptibility genes:
Paris Autism Research International Sibpair Study, Hum. Mol. Genet.
8 (1999) 805–812.
[6] A. Ashley-Koch, et al., Genetic studies of autistic disorder and
chromosome 7, Genomics 61 (1999) 227–236.
[7] J. Liu, et al., A genomewide screen for autism susceptibility loci, Am. J.
Hum. Genet. 69 (2001) 327–340.
[8] N. Risch, et al., A genomic screen of autism: evidence for a multilocus
etiology, Am. J. Hum. Genet. 65 (1999) 493–507.
[9] S. Barrett, et al., An autosomal genomic screen for autism:
collaborative linkage study of autism, Am. J. Med. Genet. 88 (1999)
609–615.
[10] Y. Shao, et al., Genomic screen and follow-up analysis for autistic
disorder, Am. J. Med. Genet. 114 (2002) 99–105.
[11] F. Tissir, A.M. Goffinet, Reelin and brain development, Nat. Rev.
Neurosci. 4 (2003) 496–505.
[12] T. Hiesberger, et al., Direct binding of Reelin to VLDL receptor and ApoE
receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates
tau phosphorylation, Neuron 24 (1999) 481–489.
[13] S.H. Fatemi, J.M. Stary, A.R. Halt, G.R. Realmuto, Dysregulation of
Reelin and Bcl-2 proteins in autistic cerebellum, J. Autism Dev. Disord.
31 (2001) 529–535.
[14] S.H. Fatemi, J.M. Stary, E.A. Egan, Reduced blood levels of reelin as a
vulnerability factor in pathophysiology of autistic disorder, Cell. Mol.
Neurobiol. 22 (2002) 139–152.
[15] A.M. Persico, et al., Reelin gene alleles and haplotypes as a factor
predisposing to autistic disorder, Mol. Psychiatry 6 (2001) 150–159.
[16] M.O. Krebs, et al., Absence of association between a polymorphic GGC
repeat in the 5V untranslated region of the reelin gene and autism, Mol.
Psychiatry 7 (2002) 801–804.
[17] H. Zhang, et al., Reelin gene alleles and susceptibility to autism spectrum
disorders, Mol. Psychiatry 7 (2002) 1012–1017.
[18] E. Bonora, et al., Analysis of reelin as a candidate gene for autism, Mol.
Psychiatry 8 (2003) 885–892.
[19] J. Li, et al., Lack of evidence for an association between WNT2 and
RELN polymorphisms and autism, Am. J. Med. Genet. B Neuropsychiatr.
Genet. 126 (2004) 51–57.
[20] B. Devlin, et al., Alleles of a reelin CGG repeat do not convey liability to
autism in a sample from the CPEA network, Am. J. Med. Genet. B
Neuropsychiatr. Genet. 126 (2004) 46–50.
[21] D.A. Skaar, et al., Analysis of the RELN gene as a genetic risk factor for
autism, Mol. Psychiatry 10 (2005) 563–571.
[22] S.H. Fatemi, J.L. Kroll, J.M. Stary, Altered levels of Reelin and its
isoforms in schizophrenia and mood disorders, Neuroreport 12 (2001)
3209–3215.
[23] S.H. Fatemi, Reelin mutations in mouse and man: from reeler mouse to
schizophrenia, mood disorders, autism and lissencephaly, Mol. Psychiatry
6 (2001) 129–133.
[24] W.M. Chen, H.W. Deng, A general and accurate approach for computing
the statistical power of the transmission disequilibrium test for complex
disease genes, Genet. Epidemiol. 21 (2001) 53–67.[25] M. Knapp, A note on power approximations for the transmission/dise-
quilibrium test, Am. J. Hum. Genet. 64 (1999) 1177–1185.
[26] T. Emahazion, et al., SNP association studies in Alzheimer’s disease
highlight problems for complex disease analysis, Trends Genet. 17 (2001)
407–413.
[27] R.S. Spielman, W.J. Ewens, The TDT and other family-based tests for
linkage disequilibrium and association, Am. J. Hum. Genet. 59 (1996)
983–989.
[28] D.J. Schaid, Case–parents design for gene–environment interaction,
Genet. Epidemiol. 16 (1999) 261–273.
[29] F. Dudbridge, B.P. Koeleman, J.A. Todd, D.G. Clayton, Unbiased
application of the transmission/disequilibrium test to multilocus haplo-
types, Am. J. Hum. Genet. 66 (2000) 2009–2012.
[30] E.R. Martin, M.P. Bass, N.L. Kaplan, Correcting for a potential bias
in the pedigree disequilibrium test, Am. J Hum. Genet. 68 (2001)
1065–1067.
[31] E.R. Martin, S.A. Monks, L.L. Warren, N.L. Kaplan, A test for linkage
and association in general pedigrees: the pedigree disequilibrium test, Am.
J. Hum. Genet 67 (2000) 146–154.
[32] D. Gordon, S.C. Heath, X. Liu, J. Ott, A transmission/disequili-
brium test that allows for genotyping errors in the analysis of
single-nucleotide polymorphism data, Am. J. Hum. Genet. 69 (2001)
371–380.
[33] U. Beffert, et al., Reelin-mediated signaling locally regulates protein
kinase B/Akt and glycogen synthase kinase 3beta, J. Biol. Chem. 277
(2002) 49958–49964.
[34] H.H. Bock, et al., PI3-kinase interacts with the adaptor protein Dab1 in
response to Reelin signaling and is required for normal cortical
lamination, J. Biol. Chem. 278 (2003) 38772–38779.
[35] Y. Benjamini, D. Drai, G. Elmer, N. Kafkafi, I. Golani, Controlling the
false discovery rate in behavior genetics research, Behav. Brain Res. 125
(2001) 279–284.
[36] D.R. Nyholt, Genetic case–control association studies—Correcting for
multiple testing, Hum. Genet. 109 (2001) 564–567.
[37] T.V. Perneger, What’s wrong with Bonferroni adjustments, BMJ 316
(1998) 1236–1238.
[38] Y. Horikawa, et al., Genetic variation in the gene encoding calpain-10
is associated with type 2 diabetes mellitus, Nat. Genet. 26 (2000)
163–175.
[39] A.A. Mitchell, D.J. Cutler, A. Chakravarti, Undetected genotyping errors
cause apparent overtransmission of common alleles in the transmission/di-
sequilibrium test, Am. J. Hum. Genet. 72 (2003) 598–610.
[40] F.J. Serajee, R. Nabi, H. Zhong, A.H. Mahbubul Huq, Association of
INPP1, PIK3CG, and TSC2 gene variants with autistic disorder:
implications for phosphatidylinositol signalling in autism, J. Med. Genet.
40 (2003) e119.
[41] H.Y. Zoghbi, Postnatal neurodevelopmental disorders: meeting at the
synapse? Science 302 (2003) 826–830.
[42] M.B. Jones, P. Szatmari, A risk-factor model of epistatic interaction,
focusing on autism, Am. J. Med. Genet. 114 (2002) 558–565.
[43] D.H. Geschwind, et al., The autism genetic resource exchange: a resource
for the study of autism and related neuropsychiatric conditions, Am. J.
Hum. Genet. 69 (2001) 463–466.
[44] C. Lord, M. Rutter, A. Le Couteur, Autism Diagnostic Interview—
Revised: a revised version of a diagnostic interview for caregivers of
individuals with possible pervasive developmental disorders, J. Autism
Dev. Disord. 24 (1994) 659–685.
[45] J.R. O’Connell, D.E. Weeks, PedCheck: a program for identification of
genotype incompatibilities in linkage analysis, Am. J. Hum. Genet. 63
(1998) 259–266.
[46] G.R. Abecasis, S.S. Cherny, W.O. Cookson, L.R. Cardon, Merlin—Rapid
analysis of dense genetic maps using sparse gene flow trees, Nat. Genet.
30 (2002) 97–101.
[47] E. Sobel, K. Lange, Descent graphs in pedigree analysis: applications to
haplotyping, location scores, and marker-sharing statistics, Am. J. Hum.
Genet. 58 (1996) 1323–1337.
[48] G.R. Abecasis, W.O. Cookson, GOLD—Graphical overview of linkage
disequilibrium, Bioinformatics 16 (2000) 182–183.
F.J. Serajee et al. / Genomics 87 (2006) 75–83 83[49] F. Dudbridge, Pedigree disequilibrium tests for multilocus haplotypes,
Genet. Epidemiol. 25 (2003) 115–121.
[50] B.P. Koeleman, F. Dudbridge, H.J. Cordell, J.A. Todd, Adaptation
of the extended transmission/disequilibrium test to distinguish
disease associations of multiple loci: the Conditional ExtendedTransmission/Disequilibrium Test, Ann. Hum. Genet. 64 (2000)
207–213.
[51] B.P. Koeleman, et al., Conditional ETDT analysis of the human
leukocyte antigen region in type 1 diabetes, Ann. Hum. Genet. 64
(2000) 215–221.
